Biotech: Pressemitteilungen - Kategorie - Seite 255

Biotech

Category / Pharmaceuticals & Biotech / Biotech


Arch Biopartners Hires Investor Relations Firm

TORONTO, ONTARIO: TORONTO, ONTARIO -- (Marketwire) -- 07/18/11 -- Arch Biopartners Inc ("Arch" or the "Company")(CNSX: ACH)(OTC: FOIFF) announced today it has retained the services of Renmark Fina ...

Functional Cure in Non-Human Primates Achieved With Simian Version of VIRxSYS' HIV Vaccine VRX1273

ROME and GAITHERSBURG, MD: Vaccine Uses Modified HIV Lentivirus Vector; HIV Virus "Very Low to Undetectable" in Reservoirs ...

Sernova to be Granted Australian Patent

LONDON, ONTARIO: LONDON, ONTARIO -- (Marketwire) -- 07/18/11 -- Sernova Corp. (TSX VENTURE: SVA) is pleased to report that the Australian Patent Office has issued a Notice of Allowance for a patent entitled "Co ...

Paladin Labs Inc. Announces Purchase of Shares of Afexa Life Sciences Inc.

MONTREAL, QUEBEC: MONTREAL, QUEBEC -- (Marketwire) -- 07/15/11 -- Paladin Labs Inc. ("Paladin")(TSX: PLB), a leading Canadian specialty pharmaceutical company, today announced it has acquired common shares ...

Novartis begins shipment of Fluvirin(R) seasonal influenza vaccine to US customers for 2011-2012 influenza season

CAMBRIDGE, MA: CAMBRIDGE, MA -- (Marketwire) -- 07/15/11 -- Novartis (NYSE: NVS)Novartis plans to ship over 30 million doses of Fluvirin vaccine to US customers for 2011-2012 season with sufficient supply to meet ...

Bradmer Pharmaceuticals Inc. Announces Termination of Proposed Reverse Take-Over Transaction With P1 Energy Corp.

TORONTO, ONTARIO: TORONTO, ONTARIO -- (Marketwire) -- 07/15/11 -- Bradmer Pharmaceuticals Inc. (TSX VENTURE: BMR.H) announced today that P1 Energy Corp. and Bradmer have mutually agreed to terminate the letter of int ...

Theratechnologies: Data Unveiled on the Effect of Tesamorelin on Metabolic Risk Factors at Conference in Italy

MONTREAL, CANADA: MONTREAL, CANADA -- (Marketwire) -- 07/15/11 -- Theratechnologies Inc. (Theratechnologies) (TSX: TH)(NASDAQ: THER) today announced the presentation of a scientific poster on a post hoc analysis whic ...

Warnex Announces the Reorganization of its Analytical Services Subsidiary

LAVAL, QUEBEC: LAVAL, QUEBEC -- (Marketwire) -- 07/15/11 -- Warnex Inc. (TSX: WNX) announced today that it is reorganizing the operations of its subsidiary, Warnex Analytical Services Inc. As part of this restruct ...

Miraculins Appoints Interim CFO

WINNIPEG, MANITOBA: WINNIPEG, MANITOBA -- (Marketwire) -- 07/15/11 -- Miraculins Inc. (TSX VENTURE: MOM) today announced the transition of its Chief Financial Officer (CFO) role from Mr. Eric Johnstone to Ms. April Man ...

ISTA Pharmaceuticals Announces Conference Call and Webcast of Second Quarter 2011 Financial Results

IRVINE, CA: IRVINE, CA -- (Marketwire) -- 07/15/11 -- ISTA Pharmaceuticals, Inc. (NASDAQ: ISTA) today announced it will release second quarter 2011 financial results after the market closes on July 28, 2011. In ...

Theravance to Report Second Quarter 2011 Financial Results on July 28, 2011

SOUTH SAN FRANCISCO, CA: SOUTH SAN FRANCISCO, CA -- (Marketwire) -- 07/14/11 -- Theravance, Inc. (NASDAQ: THRX) announced today that it will release financial results for the period ended June 30, 2011 after market close on ...

Aptalis Pharma Announces FDA Approval of 25,000 Lipase-Unit Strength of ZENPEP(R)

BRIDGEWATER, NJ: BRIDGEWATER, NJ -- (Marketwire) -- 07/14/11 -- Aptalis Pharma, a global specialty pharmaceutical company focused on gastrointestinal diseases and cystic fibrosis (CF), today announced that the U.S. ...

Arch Biopartners Announces Issuance of New U.S. Patent for Biofilm Inhibitor

TORONTO, ONTARIO: TORONTO, ONTARIO -- (Marketwire) -- 07/14/11 -- Arch Biopartners Inc ("Arch" or the "Company")(CNSX: ACH)(OTC: FOIFF) today announced the U.S. Patent and Trademark Office has iss ...

Prana Announces At-The-Market Issuance Program

MELBOURNE, AUSTRALIA: MELBOURNE, AUSTRALIA -- (Marketwire) -- 07/13/11 -- Prana Biotechnology Limited (NASDAQ: PRAN) (ASX: PBT) today announced that it has filed a prospectus supplement to sell up to an aggregate 50,000, ...

Thallion Announces 2011 Second Quarter Results

MONTREAL, QUEBEC: MONTREAL, QUEBEC -- (Marketwire) -- 07/13/11 -- Thallion Pharmaceuticals Inc. (TSX: TLN) today announced its operational and financial results for the three-month and six-month periods ended May 31, ...


Seite 255 von 255:  « ..  251  252  253  254 255





 

Werbung



Facebook

Sponsoren

foodir.org The food directory für Deutschland
Informationen für Feinsnacker finden Sie hier.

Firmenverzeichniss

Firmen die firmenpresse für ihre Pressearbeit erfolgreich nutzen
1 2 3 4 5 6 7 8 9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z